REFERENCE STUDY FOR PHARMACOGENOMICS GWAS
Genome-wide Association Studies of Drug Response and Toxicity: An Opportunity for Genome Medicine. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443656/#!po=35.7143

PHARMACOGENOMICS GWAS STUDIES WITH SUMMARY DATA
Antidepressants
Perroud N, Uher R, Ng MY, Guipponi M, Hauser J, Henigsberg N, Maier W, Mors O, Gennarelli M, Rietschel M, Souery D, Dernovsek MZ, Stamp AS, Lathrop M, Farmer A, Breen G, Aitchison KJ, Lewis CM, Craig IW, McGuffin P. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J. 2012 Feb;12(1):68-77. doi: 10.1038/tpj.2010.70. Epub 2010 Sep 28. PMID: 20877300. https://pubmed.ncbi.nlm.nih.gov/20877300/
Summary Data: https://www.ebi.ac.uk/gwas/publications/20877300
Drugs: Escitalopram; Nortriptyline
ADR: Increasing suicidal ideation
Odds of increasing suicidal ideation in population sample: 244/462

Kurose K, Hiratsuka K, Ishiwata K, Nishikawa J, Nonen S, Azuma J, Kato M, Wakeno M, Okugawa G, Kinoshita T, Kurosawa T, Hasegawa R, Saito Y. Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression. Psychiatry Res. 2012 Aug 15;198(3):424-9. doi: 10.1016/j.psychres.2012.01.023. Epub 2012 Mar 23. PMID: 22445761. https://pubmed.ncbi.nlm.nih.gov/22445761/
Summary Data: https://www.ebi.ac.uk/gwas/publications/22445761
Drugs: Paroxetine (SSRI); Fluvoxamine (SSRI); Milnacipran (SNRI)
ADR: Sexual dysfunction
Odds of sexual dysfunction in population sample: 36/165

Antipsychotics
Saito T, Ikeda M, Mushiroda T, Ozeki T, Kondo K, Shimasaki A, Kawase K, Hashimoto S, Yamamori H, Yasuda Y, Fujimoto M, Ohi K, Takeda M, Kamatani Y, Numata S, Ohmori T, Ueno S, Makinodan M, Nishihata Y, Kubota M, Kimura T, Kanahara N, Hashimoto N, Fujita K, Nemoto K, Fukao T, Suwa T, Noda T, Yada Y, Takaki M, Kida N, Otsuru T, Murakami M, Takahashi A, Kubo M, Hashimoto R, Iwata N. Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population. Biol Psychiatry. 2016 Oct 15;80(8):636-42. doi: 10.1016/j.biopsych.2015.12.006. Epub 2016 Feb 11. PMID: 26876947. https://pubmed.ncbi.nlm.nih.gov/26876947/
Summary Data: https://www.ebi.ac.uk/gwas/publications/26876947
Drugs: Clozapine
ADR: Clozapine-induced agranulocytosis/granulocytopenia
Odds of clozapine-induced agranulocytosis in population sample: 23/29

Lacaze P, Ronaldson KJ, Zhang EJ, Alfirevic A, Shah H, Newman L, Strahl M, Smith M, Bousman C, Francis B, Morris AP, Wilson T, Rossello F, Powell D, Vasic V, Sebra R, McNeil JJ, Pirmohamed M. Genetic associations with clozapine-induced myocarditis in patients with schizophrenia. Transl Psychiatry. 2020 Jan 27;10(1):37. doi: 10.1038/s41398-020-0722-0. PMID: 32066683; PMCID: PMC7026069. https://pubmed.ncbi.nlm.nih.gov/32066683/
Summary Data: https://www.ebi.ac.uk/gwas/publications/32066683
Drugs: Clozapine
ADR: Clozapine-induced myocarditis
Odds of clozapine-induced myocarditis in population sample: 33/62

Maciukiewicz M, Tiwari AK, Zai CC, Gorbovskaya I, Laughlin CP, Nurmi EL, Liebermann JA, Meltzer HY, Kennedy JL, MÃ¼ller DJ. Genome-wide association study on antipsychotic-induced weight gain in Europeans and African-Americans. Schizophr Res. 2019 Oct;212:204-212. doi: 10.1016/j.schres.2019.07.022. Epub 2019 Aug 22. PMID: 31447353. https://pubmed.ncbi.nlm.nih.gov/31447353/
Summary Data: https://www.ebi.ac.uk/gwas/studies/GCST009302
Drugs: Clozapine; Olanzapine
ADR: Weight gain
